StablecoinX's shares rose over 12% following the disclosure of its 3-billion-token ENA treasury valued at $218.4 million and its first quarterly report as a public company. The company reported a $34.2 million net loss mainly due to a non-cash impairment charge but showed initial revenue of $62,372 from infrastructure services. StablecoinX controls about 20% of ENA's total supply and is expanding its business lines, including a new middleware platform and planned distribution services. The company's future performance depends on the market price of ENA tokens and regulatory conditions, with ongoing institutional interest in its USDe stablecoin products.
Industrial Alliance Securities lowered Abeona Therapeutics' price target from $20 to $15 following a 14% stock drop after the company reported Q2 revenues of $11.4 million, missing analyst expectations. The company faces operational challenges with i...
Inovio Pharmaceuticals is progressing its DNA medicine pipeline with its lead candidate INO-3107 for Recurrent Respiratory Papillomatosis under FDA accelerated review, targeting a decision by October 30, 2026. The company raised $18.3 million in fund...
Morin Brit, a director at Life360, sold 15,582 shares of the company, generating $1 million from the transaction. This sale may indicate a personal financial decision or portfolio adjustment by the director. Investors might watch for any further insi...
AbCellera Biologics announced positive Phase 2 trial results for its experimental menopause drug ABCL635, which significantly reduced hot flash frequency by 83%. The stock surged 33.19% to a 52-week high of $11.32, boosting the company's market cap t...
TOMI Environmental Solutions reported a 118% year-over-year revenue increase to $2.25 million, surpassing analyst estimates of $1.84 million. The company also beat EPS expectations with a loss of $0.05 per share, better than the anticipated loss of $...
